Can-Fite BioPharma Ltd.CANFNYSE
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank29
Year-over-Year Change
Year-over-year gross profit growth rate
Percentile
P29
Within normal range
vs 3Y Ago
-0.8x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -9.29% |
| 2023 | -8.27% |
| 2022 | -5.04% |
| 2021 | 11.80% |
| 2020 | -62.45% |
| 2019 | -46.81% |
| 2018 | 352.21% |
| 2017 | 398.38% |
| 2016 | 2.90% |
| 2015 | 0.00% |